Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Pulmonary Hypertension

  Free Subscription


17.07.2017

1 Am J Perinatol
1 Am J Physiol Lung Cell Mol Physiol
1 Ann Card Anaesth
1 Arterioscler Thromb Vasc Biol
1 BMC Pediatr
1 BMJ Case Rep
1 Br J Pharmacol
1 Cell Physiol Biochem
1 Clin Cardiol
1 Eur J Intern Med
1 Eur J Pediatr
1 EuroIntervention
1 Int Heart J
1 J Zhejiang Univ Sci B
1 Neonatology
1 Oncotarget
2 PLoS One
1 Respir Investig
1 Ter Arkh
1 Zhong Nan Da Xue Xue Bao Yi Xue Ban


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Perinatol

  1. SAGHEB S, Sepidarkish M, Mohseni SO, Movahedian A, et al
    Red Cell Distribution Width as a Predictor of Persistent Pulmonary Hypertension of the Newborn.
    Am J Perinatol. 2017 Jul 13. doi: 10.1055/s-0037-1604246.
    PubMed     Text format    


    Am J Physiol Lung Cell Mol Physiol

  2. NAGY BM, Nagaraj C, Meinitzer A, Sharma N, et al
    Importance of kynurenine in pulmonary hypertension.
    Am J Physiol Lung Cell Mol Physiol. 2017 Jul 13:ajplung.00517.2016.
    PubMed     Text format     Abstract available


    Ann Card Anaesth

  3. BARNWAL NK, Umbarkar SR, Sarkar MS, Dias RJ, et al
    Randomized comparative study of intravenous infusion of three different fixed doses of milrinone in pediatric patients with pulmonary hypertension undergoing open heart surgery.
    Ann Card Anaesth. 2017;20:318-322.
    PubMed     Text format     Abstract available


    Arterioscler Thromb Vasc Biol

  4. HOOD KY, Mair KM, Harvey AP, Montezano AC, et al
    Serotonin Signaling Through the 5-HT1B Receptor and NADPH Oxidase 1 in Pulmonary Arterial Hypertension.
    Arterioscler Thromb Vasc Biol. 2017;37:1361-1370.
    PubMed     Text format     Abstract available


    BMC Pediatr

  5. VYAS-READ S, Kanaan U, Shankar P, Stremming J, et al
    Early characteristics of infants with pulmonary hypertension in a referral neonatal intensive care unit.
    BMC Pediatr. 2017;17:163.
    PubMed     Text format     Abstract available


    BMJ Case Rep

  6. FFRENCH-O'CARROLL R, Biancardi B, Tujjar O
    Malar rash with pulmonary hypertension and chronic obstructive pulmonary disease.
    BMJ Case Rep. 2017;2017.
    PubMed     Text format    


    Br J Pharmacol

  7. COLLUM SD, Chen NY, Hernandez AM, Hanmandlu A, et al
    Inhibition of Hyaluronan Synthesis Attenuates Pulmonary Hypertension Associated with Lung Fibrosis.
    Br J Pharmacol. 2017 Jul 8. doi: 10.1111/bph.13947.
    PubMed     Text format     Abstract available


    Cell Physiol Biochem

  8. YU L, Tu Y, Jia X, Fang K, et al
    Resveratrol Protects Against Pulmonary Arterial Hypertension in Rats via Activation of Silent Information Regulator 1.
    Cell Physiol Biochem. 2017;42:55-67.
    PubMed     Text format     Abstract available


    Clin Cardiol

  9. MWANSA H, Bilchick KC, Parker AM, Harding W, et al
    Decreased pulmonary arterial proportional pulse pressure is associated with increased mortality in group 1 pulmonary hypertension.
    Clin Cardiol. 2017 Jul 10. doi: 10.1002/clc.22752.
    PubMed     Text format     Abstract available


    Eur J Intern Med

  10. CORREALE M, Zicchino S, Monaco I, Di Biase M, et al
    Angiotensin-converting enzyme inhibitors, angiotensin II receptors antagonists, beta-blockers and ivabradine as supportive therapy in pulmonary hypertension: Drug safety and tolerability.
    Eur J Intern Med. 2017 Jul 9. pii: S0953-6205(17)30284.
    PubMed     Text format    


    Eur J Pediatr

  11. ROWCLIFF K, de Waal K, Mohamed AL, Chaudhari T, et al
    Noradrenaline in preterm infants with cardiovascular compromise.
    Eur J Pediatr. 2016.
    PubMed     Text format     Abstract available


    EuroIntervention

  12. ARASZKIEWICZ A, Jankiewicz S, Mularek-Kubzdela T, Lesiak M, et al
    Stepwise optimisation of balloon pulmonary angioplasty in a patient with severe non-operable chronic thromboembolic pulmonary hypertension.
    EuroIntervention. 2017 Jul 11. pii: EIJ-D-17-00382. doi: 10.4244/EIJ-D-17-00382.
    PubMed     Text format    


    Int Heart J

  13. SUGIMOTO K, Nakazato K, Sakamoto N, Yamaki T, et al
    Pulmonary Artery Diameter Predicts Lung Injury After Balloon Pulmonary Angioplasty in Patients With Chronic Thromboembolic Pulmonary Hypertension.
    Int Heart J. 2017 Jul 13. doi: 10.1536.
    PubMed     Text format     Abstract available


    J Zhejiang Univ Sci B

  14. TAN X, Juan FG, Shah AQ
    Involvement of endothelial progenitor cells in the formation of plexiform lesions in broiler chickens: possible role of local immune/inflammatory response.
    J Zhejiang Univ Sci B. 2017;18:59-69.
    PubMed     Text format     Abstract available


    Neonatology

  15. HUTSON S, Baerg J, Deming D, St Peter SD, et al
    High Prevalence of Pulmonary Hypertension Complicates the Care of Infants with Omphalocele.
    Neonatology. 2017;112:281-286.
    PubMed     Text format     Abstract available


    Oncotarget

  16. SHANG X, Xiao S, Dong N, Lu R, et al
    Assessing right ventricular function in pulmonary hypertension patients and the correlation with the New York Heart Association (NYHA) classification.
    Oncotarget. 2017 Jul 5. doi: 10.18632/oncotarget.19026.
    PubMed     Text format     Abstract available


    PLoS One

  17. FARHA S, Hu B, Comhair S, Zein J, et al
    Mitochondrial Haplogroups and Risk of Pulmonary Arterial Hypertension.
    PLoS One. 2016;11:e0156042.
    PubMed     Text format     Abstract available

  18. SAHOO S, Meijles DN, Al Ghouleh I, Tandon M, et al
    MEF2C-MYOCD and Leiomodin1 Suppression by miRNA-214 Promotes Smooth Muscle Cell Phenotype Switching in Pulmonary Arterial Hypertension.
    PLoS One. 2016;11:e0153780.
    PubMed     Text format     Abstract available


    Respir Investig

  19. YAMAMOTO K, Tanabe N, Suda R, Sasaki A, et al
    Riociguat for patients with chronic thromboembolic pulmonary hypertension: Usefulness of transitioning from phosphodiesterase type 5 inhibitor.
    Respir Investig. 2017;55:270-275.
    PubMed     Text format     Abstract available


    Ter Arkh

  20. MOISEEVA OM, Rudakova AV
    [Pharmacoeconomic aspects of macitentan in the therapy of pulmonary arterial hypertension].
    Ter Arkh. 2017;89:72-77.
    PubMed     Text format     Abstract available


    Zhong Nan Da Xue Xue Bao Yi Xue Ban

  21. LEI S, Tang D, Xu N, Wu S, et al
    [Investigation and analysis for current situation and pathogenesis relevant to pulmonary hypertension].
    Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2017;42:641-646.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Pulmonary Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: